Bg pattern

CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Informationfortheuser

Carmelosa Stada 5 mg/ml eye drops solution in single-dose container

Carmelosa sodium

Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.

Follow the administration instructions of the medication contained in this package leaflet or as indicated by your doctor or pharmacist.

  • Keep this package leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.
  • You should consult a doctor if it worsens or does not improve after 3 days.

Contents of the package leaflet:

  1. What is Carmelosa Stada and what is it used for
  2. What you need to know before starting to use Carmelosa Stada
  3. How to use Carmelosa Stada
  4. Possible side effects
  5. Storage of Carmelosa Stada
  6. Contents of the container and additional information

1. What is Carmelosa Stada and what is it used for

Carmelosa Stada belongs to a group of medications called artificial tears, it is a tear substitute and contains a lubricant called carmelosa sodium. This medication is used for the symptomatic relief of eye irritation and dryness.

You should consult a doctor if it worsens or does not improve after 3 days.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use Carmelosa Stada

Do not use Carmelosa Stada

If you are allergic to carmelosa sodium or any of the other components of this medication (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to use Carmelosa Stada.

If irritation, pain, redness, or changes in vision occur, or if you consider that your condition worsens, stop using this medication and consult your doctor or pharmacist.

Using Carmelosa Stada with other medications

Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.

Pregnancyand breastfeeding and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

This medication can be used during pregnancy and breastfeeding.

Driving and using machines

This medication may cause temporary blurred vision, usually lasting 1 to 15 minutes. If you experience temporary blurred vision, do not drive or use machines until your vision is clear.

3. How to use Carmelosa Stada

Follow the administration instructions of the medication contained in this package leaflet or as indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.

Carmelosa Stada is used via the ocular route (applied to the eye).

The recommended dose is one drop in the affected eye(s) as needed or as indicated by your specialist.

Make sure the single-dose container is intact before use. The solution should be used immediately after opening. To avoid possible contamination of the dropper and the solution, the dropper should not come into contact with the eye or any other surface.

Wash your hands before use.

For correct administration, follow these instructions:

  1. Remove a single-dose container from the strip.

Hand holding a device with clamps and elastic bands applied to a flexed finger with an arrow indicating movement

  1. Check that the single-dose container is not damaged.
  1. Hold the single-dose container between the index and thumb fingers of one hand.

With the index and thumb fingers of the other hand, perform a slight lever on the winged piece to open it. Do not twist to break.

Hands holding a device with a transparent plunger and a needle, showing finger pressure on the plunger

  1. Gently pull to remove the winged piece.

Hand holding a pen or pencil with two fingers and thumb pointing to the right

  1. Gently pull down the lower eyelid to form a pouch. Turn the single-dose container upside down and squeeze to apply one drop to each eye. Blink a few times.

Hand holding a nasal applicator pressing the nozzle into a nostril with the index finger holding the other side

Do not reuse the single-dose container even if there is remaining solution.

If more than one eye medication is used, the applications of the different medications should be spaced at least 5 minutes apart.

If you use more Carmelosa Stada than you should

It will not cause you any harm. If you are concerned, talk to your doctor or pharmacist.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, Telephone 91 562 04 20, indicating the medication and the amount administered or ingested.

If you forget to use Carmelosa Stada

Apply the next dose as needed, or following the usual schedule indicated by your doctor or pharmacist. Do not use a double dose to make up for forgotten doses.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

The adverse reactions or side effects that are medically relevant and mentioned below have been identified in clinical trials:

Common side effects(may affect up to 1 in 10 patients):

Ocular irritation (including burning and discomfort), eye pain, ocular itching, visual disturbances.

Post-marketing experience

The adverse reactions or side effects that are medically relevant and mentioned below have been reported in post-marketing experience:

Uncommon side effects(may affect up to 1 in 100 people):

Allergic reaction (including ocular or eyelid inflammation), blurred vision, increased tear production (also known as lacrimation), sticky eye, crust on the eyelid and/or medication residue, ocular or eyelid redness, worsening of vision, injury to the eye surface due to the dropper coming into contact with the eye during administration of the eye drops.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them through the Spanish Pharmacovigilance System for Human Use Medications. https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Carmelosa Stada

Keep this medication out of sight and reach of children.

Do not use this medication after the expiration date stated on the container after "EXP". The expiration date is the last day of the month indicated.

Store the single-dose containers in the original packaging.

Discard the opened single-dose container after use (do not reuse the container once opened for subsequent doses).

Do not use this medication if you notice that the solution changes color or becomes cloudy.

Medications should not be disposed of through wastewater or household waste. Deposit the containers and medications you no longer need at the Sigre Collection Point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.

6. Contents of the container and additional information

Composition of Carmelosa Stada

  • The active ingredient is carmelosa sodium. Each ml of solution contains 5 mg of carmelosa sodium.
  • The other components are sodium chloride, sodium lactate, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium hydroxide, hydrochloric acid, and water for injectable preparations.

The components of Carmelosa Stada have been designed to simulate the natural composition of your tear.

Appearance of the product and contents of the container

Carmelosa Stada is presented in single-dose containers of 0.4 ml of sterile solution. Each cardboard box contains an aluminum bag with 10 or 30 single-dose containers.

Only some container sizes may be marketed.

Marketing authorization holder

Laboratorio STADA, S.L.

Frederic Mompou, 5

08960 Sant Just Desvern (Barcelona)

Spain

[email protected]

Manufacturer

Neuraxpharm Pharmaceuticals, S.L.

Avda. Barcelona 69

08970 Sant Joan Despí (Barcelona)

Spain

Date of the last revision of this package leaflet:January 2018

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es

Online doctors for CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS

Discuss questions about CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS?
CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS?
The active ingredient in CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS is artificial tears and other indifferent preparations. This information helps identify medicines with the same composition but different brand names.
How much does CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS cost in pharmacies?
The average pharmacy price for CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS is around 6.88 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS?
CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS is manufactured by Laboratorio Stada S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CARMELOSE STADA 5 mg/ml EYE DROPS SOLUTION IN SINGLE-DOSE CONTAINERS?
Other medicines with the same active substance (artificial tears and other indifferent preparations) include ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS, ARTIFIC 3.20 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS, ARTIFIC 3.20 mg/ml EYE DROPS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media